Ketamine-Assisted EMDR™ (KA-EMDR) vs MDMA-Assisted Therapy
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
Ketamine-Assisted EMDR™ (KA-EMDR)
- Tradition
- Integrative
- Founder
- Danielle Ciccone & Michele Topel (2024)
- Review status
- Assessment not yet completed
- Focus
- Somatic + Cognitive
- Format
- Individual
- Duration
- Short to Medium
MDMA-Assisted Therapy
- Tradition
- Psychedelic
- Founder
- MAPS / Mithoefer (2021)
- Review status
- 4 source checks available
- Official sources
Guidelines and official sources (4)
3 clinical guideline checks · 1 regulatory source check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- NDA 215455: midomafetamine complete response letter
Not a treatment recommendation
The letter verifies the 2024 nonapproval decision and identifies safety reporting, durability and bias concerns. Psychotherapy-contribution questions appear separately as additional comments.
Scope: Midomafetamine application NDA 215455 for PTSD
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Insufficient evidence for or against
VA/DoD finds insufficient evidence for or against MDMA-assisted psychotherapy. The guideline’s evidence cutoff precedes later trials and regulatory decisions.
Scope: MDMA-assisted psychotherapy for adults with PTSD; evidence reviewed through May 2022.
- Management of Major Depressive Disorder
Recommendation against the stated use
VA/DoD strongly recommends against MDMA for MDD outside research. This 2022 guideline used evidence through January 2021; it does not assess later trials or every diagnosis.
Scope: MDMA for MDD outside research settings.
- Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults
Insufficient evidence for or against
APA finds insufficient evidence for or against this intervention in the reviewed comparisons.
Scope: Adults with PTSD; MDMA-assisted psychotherapy versus the inactive or low-dose active comparators reviewed.
- NDA 215455: midomafetamine complete response letter
- Focus
- Experiential + Processing
- Format
- Individual (co-therapist)
- Duration
- Short (3 sessions)
How they work
Ketamine-Assisted EMDR™ (KA-EMDR)
Core mechanism: Standard 8-phase EMDR protocol adapted for ketamine integration. Client self-administers low-dose sublingual ketamine (troches) at a strategically timed point during the reprocessing phases. The psycholytic dose is intended to expand the window of tolerance and enhance neuroplasticity while preserving the client's capacity to engage in bilateral stimulation and verbal processing, unlike higher-dose psychedelic approaches that impair interactive participation.
Ontology: Traumatic memories are stored in maladaptive neural networks (per EMDR's Adaptive Information Processing model). Low-dose ketamine enhances neuroplasticity and the memory reconsolidation window, allowing EMDR's bilateral stimulation to reprocess traumatic material more effectively. The pharmacological and psychotherapeutic mechanisms are proposed as synergistic rather than additive.
MDMA-Assisted Therapy
Core mechanism: MDMA reduces the fear response and increases trust and empathy, making it possible to stay with trauma material inside the therapeutic relationship
Ontology: PTSD maintained by overwhelming fear that prevents therapeutic engagement; MDMA lowers this barrier pharmacologically
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
1 shared · 0 Ketamine-Assisted EMDR™ (KA-EMDR)-only · 1 MDMA-Assisted Therapy-only
Linked to both entries
Linked only in the MDMA-Assisted Therapy entry
What each assumes — and misses
Ketamine-Assisted EMDR™ (KA-EMDR)
Philosophical roots: Inherits EMDR's basis in information processing theory and memory reconsolidation science. The ketamine component draws on psycholytic therapy tradition (Passie et al., 2022): the use of sub-psychedelic doses to enhance psychotherapeutic process rather than induce altered states as the primary intervention.
Blind spots: Rests on a single uncontrolled pilot study with no comparator, run by the modality's own developers; requires the client to self-administer a Schedule III dissociative anesthetic mid-session rather than have it clinician-administered; the protocol name is trademarked and taught only through the founders' own institute, the same training-revenue structure flagged elsewhere on this site; combines two modalities, ketamine and EMDR's bilateral stimulation, whose interaction has not been independently studied, so the claimed synergy between pharmacological and psychotherapeutic mechanisms is a hypothesis, not a finding
Therapeutic voice: The dose is low on purpose. You should still be able to talk to me and follow the tapping, and if it gets to be too much we stop the set and stay with the breathing until you're back.
MDMA-Assisted Therapy
Philosophical roots: Mithoefer (inner healing intelligence); Rogers (organismic wisdom, given conditions); Buber (I-Thou enabled pharmacologically); trauma processing theory
Blind spots: FDA declined approval (2024); methodological concerns about unblinding; not currently legally available outside research
Therapeutic voice: You're safe here. If something difficult comes up, you can move toward it. You don't have to do this alone.
Choosing between them
Ketamine-Assisted EMDR™ (KA-EMDR) (Integrative) and MDMA-Assisted Therapy (Psychedelic) come from different traditions, which means they assume different things about what a person is, what causes suffering, and what the therapeutic relationship is for. The choice between them is often less about "which works better" and more about which set of assumptions fits the client and the therapist.
For deeper coverage: see the full Ketamine-Assisted EMDR™ (KA-EMDR) and MDMA-Assisted Therapy pages, or use the interactive comparison tool to add more modalities to this comparison.